177 related articles for article (PubMed ID: 6664229)
1. Relative ability of N-methyl nalorphine and N-methyl levallorphan to prevent antinociception and intestinal transit inhibition in morphine treated rats.
Notarnicola A; Landi M; Bianchi G; Tavani A
Life Sci; 1983; 33 Suppl 1():481-4. PubMed ID: 6664229
[TBL] [Abstract][Full Text] [Related]
2. Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivity.
Bianchi G; Fiocchi R; Tavani A; Manara L
Life Sci; 1982 May; 30(22):1875-83. PubMed ID: 7109826
[TBL] [Abstract][Full Text] [Related]
3. Levallorphan methyl iodide (SR 58002), a potent narcotic antagonist with peripheral selectivity superior to that of other quaternary compounds.
Dragonetti M; Bianchetti A; Sacilotto R; Giudice A; Ferrarese N; Cattaneo C; Manara L
Life Sci; 1983; 33 Suppl 1():477-80. PubMed ID: 6664228
[TBL] [Abstract][Full Text] [Related]
4. The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestine.
Bianchi G; Fiocchi R; Peracchia F; Petrillo P; Tavani A; Manara L
J Pharm Pharmacol; 1984 May; 36(5):326-30. PubMed ID: 6145770
[TBL] [Abstract][Full Text] [Related]
5. Antagonism by N-methyl levallorphan-methane sulphonate (SR 58002 C) of morphine-elicited acute and chronic central and peripheral effects.
Sbacchi M; Colombo M; La Regina A; Petrillo P; Tavani A
Life Sci; 1988; 42(21):2079-89. PubMed ID: 3386393
[TBL] [Abstract][Full Text] [Related]
6. Effects of narcotic analgesics and antagonists on the in vivo release of acetylcholine from the cerebral cortex of the cat.
Jhamandas K; Phillis JW; Pinsky C
Br J Pharmacol; 1971 Sep; 43(1):53-66. PubMed ID: 5136464
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological actions of levallorphan allyl bromide (CM 32191), a new peripheral narcotic antagonist.
Bianchetti A; Giudice A; Picerno N; Carminati P
Life Sci; 1982 Nov 15-22; 31(20-21):2261-4. PubMed ID: 6186879
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of opiate mydriasis in mice.
Korczyn AD; Rock M
Br J Pharmacol; 1981 Aug; 73(4):807-10. PubMed ID: 7272583
[TBL] [Abstract][Full Text] [Related]
9. Quaternary derivatives of narcotic antagonists: stereochemical requirements at the chiral nitrogen for in vitro and in vivo activity.
Bianchetti A; Nisato D; Sacilotto R; Dragonetti M; Picerno N; Tarantino A; Manara L; Angel LM; Simon EJ
Life Sci; 1983; 33 Suppl 1():415-8. PubMed ID: 6319895
[TBL] [Abstract][Full Text] [Related]
10. Interactions of narcotic antagonists and antagonist-analgesics.
Blane GF; Dugdall D
J Pharm Pharmacol; 1968 Jul; 20(7):547-52. PubMed ID: 4386612
[No Abstract] [Full Text] [Related]
11. Agonist and antagonist actions of morphine-like drugs on the guinea-pig isolated ileum.
Gyand EA; Kosterlitz HW
Br J Pharmacol Chemother; 1966 Sep; 27(3):514-27. PubMed ID: 5970903
[No Abstract] [Full Text] [Related]
12. The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone).
Jasinski DR; Martin WR; Haertzen CA
J Pharmacol Exp Ther; 1967 Aug; 157(2):420-6. PubMed ID: 6039832
[No Abstract] [Full Text] [Related]
13. Modification of the analgesic action of pethidine and morphine by three opiate antagonists, a respiratory stimulant (doxapram) and an analeptic (nikethamide); a study using an experimental pain stimulus in man.
Dundee JW; Gupta PK; Jones CJ
Br J Pharmacol; 1973 Jun; 48(2):326P. PubMed ID: 4733735
[No Abstract] [Full Text] [Related]
14. STUDIES ON MORPHINE. I. EFFECTS OF NALORPHINE AND LEVALLORPHAN IN MICE IMPLANTED WITH PELLETS OF MORPHINE.
HUIDOBRO F; MAGGIOLO C; CONTRERAS E
Arch Int Pharmacodyn Ther; 1963 Jul; 144():196-205. PubMed ID: 14043644
[No Abstract] [Full Text] [Related]
15. Behavioural effects of some morphine antagonists and hallucinogens in the rat.
Schneider C
Nature; 1968 Nov; 220(5167):586-7. PubMed ID: 5686733
[No Abstract] [Full Text] [Related]
16. Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone).
Kosterlitz HW; Watt AJ
Br J Pharmacol Chemother; 1968 Jun; 33(2):266-76. PubMed ID: 5664147
[No Abstract] [Full Text] [Related]
17. Counteraction of narcotic antagonist analgesics by the narcotic antagonist Naloxone.
Blumberg H; Dayton HB; Wolf PS
Proc Soc Exp Biol Med; 1966 Dec; 123(3):755-8. PubMed ID: 4381176
[No Abstract] [Full Text] [Related]
18. The analgesic effect of opiate-opiate antagonist combinations in the rat.
Grumbach L; Chernov HI
J Pharmacol Exp Ther; 1965 Sep; 149(3):385-96. PubMed ID: 5848049
[No Abstract] [Full Text] [Related]
19. Morphine no longer blocks gastrointestinal transit but retains antinociceptive action in diallylnormorphine-pretreated rats.
Tavani A; Bianchi G; Manara L
Eur J Pharmacol; 1979 Oct; 59(1-2):151-4. PubMed ID: 510395
[TBL] [Abstract][Full Text] [Related]
20. Effect of N-allylnormorphine and levallorphan on respiration during and after ether anesthesia.
MAY G; PHILLIPS M; ADRIANI J
Anesthesiology; 1957; 18(6):871-7. PubMed ID: 13478895
[No Abstract] [Full Text] [Related]
[Next] [New Search]
